Phentermine

Régine Béliard Veillard, PharmD, BCACP, TTS, Clare Lee, M.D., MHS, Stacy Elder Dalpoas, Pharm.D., BCP, Reza Alavi, M.D.

INDICATIONS

FDA

  • Adult and pediatric patients older than 16 years of age for short-term management of obesity (adjunct to weight reduction program of exercise, behavioral modification and caloric restriction) in patients with an initial BMI ≥ 30 kg/m2, or BMI ≥ 27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 2, 2022